Multidrug Resistance of Gastric Cancer: The Mechanisms and Chinese Medicine Reversal Agents
- PMID: 33293864
- PMCID: PMC7719322
- DOI: 10.2147/CMAR.S274599
Multidrug Resistance of Gastric Cancer: The Mechanisms and Chinese Medicine Reversal Agents
Abstract
Chemotherapy is the main clinical treatment method of gastric cancer. Multidrug resistance (MDR) has become a common phenomenon with the development of tumors, which alleviates the effect of chemotherapy and makes it difficult to break the bottleneck of survival rate of advanced gastric cancer. Therefore, the exploration of MDR reversal agents for gastric cancer is the focus and also the difficulty of current treatment. Currently, the researches on the mechanisms of drug resistance in gastric cancer have been continuously deepened, which reveal different pathways and targets of MDR, laying a solid foundation for studying reversal agents. As a kind of natural medicine, traditional Chinese medicine (TCM) owns the characteristics of low toxicity, high safety and effectiveness. It can inhibit the occurrence, growth and metastasis of tumors, and reverse MDR via multiple pathways and mechanisms, the pathological function of which has become a research hotspot in recent years. TCM reversers are mainly divided into Chinese medicine monomers, Chinese patent medicines, and Chinese herbal compounds. With certain quantity and advantage, TCM reversers for MDR play an important role in the clinical treatment and show great potential in gastric cancer.
Keywords: MDR; TCM; gastric cancer; mechanisms; multidrug resistance; review; traditional Chinese medicine.
© 2020 Huang et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures
Similar articles
-
Traditional Chinese medicine reverses cancer multidrug resistance and its mechanism.Clin Transl Oncol. 2022 Mar;24(3):471-482. doi: 10.1007/s12094-021-02716-4. Epub 2021 Oct 13. Clin Transl Oncol. 2022. PMID: 34643878 Review.
-
Research Progress of Traditional Chinese Medicine Monomers in Reversing Multidrug Resistance of Breast Cancer.Am J Chin Med. 2023;51(3):575-594. doi: 10.1142/S0192415X23500283. Epub 2023 Feb 23. Am J Chin Med. 2023. PMID: 36823097 Review.
-
[Exploration and practice of post-marketing survival benefit evaluation of Chinese patent medicine for cancer].Zhongguo Zhong Yao Za Zhi. 2021 Apr;46(8):1980-1987. doi: 10.19540/j.cnki.cjcmm.20210205.502. Zhongguo Zhong Yao Za Zhi. 2021. PMID: 33982508 Chinese.
-
Effect of traditional Chinese medicine components on multidrug resistance in tumors mediated by P-glycoprotein.Oncol Lett. 2017 Jun;13(6):3989-3996. doi: 10.3892/ol.2017.5976. Epub 2017 Apr 3. Oncol Lett. 2017. PMID: 28588693 Free PMC article.
-
Research Progress on Reversing Multidrug Resistance in Tumors by Using Chinese Medicine.Chin J Integr Med. 2018 Jun;24(6):474-480. doi: 10.1007/s11655-018-2910-1. Epub 2018 Jun 2. Chin J Integr Med. 2018. PMID: 29860581 Review.
Cited by
-
A novel deep learning segmentation model for organoid-based drug screening.Front Pharmacol. 2022 Dec 14;13:1080273. doi: 10.3389/fphar.2022.1080273. eCollection 2022. Front Pharmacol. 2022. PMID: 36588731 Free PMC article.
-
The inhibitory effect and mechanism of Yi-qi-hua-yu-jie-du decoction on the drug resistance of gastric cancer stem cells based on ABC transporters.Chin Med. 2022 Aug 9;17(1):93. doi: 10.1186/s13020-022-00647-y. Chin Med. 2022. PMID: 35941687 Free PMC article.
-
Long non-coding RNA PVT1: A promising chemotherapy and radiotherapy sensitizer.Front Oncol. 2022 Jul 29;12:959208. doi: 10.3389/fonc.2022.959208. eCollection 2022. Front Oncol. 2022. PMID: 35965522 Free PMC article. Review.
-
In vitro cytotoxic activity on KATO-III cancer cell lines of mangiferolic acid purified from Thai Tetragonula laeviceps propolis.Heliyon. 2024 Apr 27;10(9):e30436. doi: 10.1016/j.heliyon.2024.e30436. eCollection 2024 May 15. Heliyon. 2024. PMID: 38711626 Free PMC article.
-
Advances in the anti-tumor mechanisms of saikosaponin D.Pharmacol Rep. 2024 Aug;76(4):780-792. doi: 10.1007/s43440-024-00569-6. Epub 2024 Jul 4. Pharmacol Rep. 2024. PMID: 38965200 Review.
References
-
- Zuo T, Zheng R, Zeng H, Zhang S, Chen W. Epidemiology of stomach cancer in China. Chin J Clin Oncol. 2017;44(1):52–58.
-
- Marin JJ, Al-Abdulla R, Lozano E, et al. Mechanisms of resistance to chemotherapy in gastric cancer anticancer agents. Med Chem. 2016;16(3):318–334. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials